In the current pharmaceutical manufacturing environment, linking information technology (IT) with operational technology (OT) systems is increasingly vital. This integration enables a seamless exchange of information between these two historically separate domains – one focused on data management and the other on overseeing physical operations. This enables various aspects of the manufacturing process to gain insights from one another to boost efficiency and refine strategic decision-making. Digital transformation is essential for directing companies through the complexities of implementation and ensuring a seamless shift to a data-driven, digitally optimised manufacturing landscape. Singapore has been viewed as a global hub in Asia for many years, and has strived to stay ahead of the curve when it comes to technology adoption. The city-state has undergone continued transformation, emerging as a global hub for digital manufacturing, notably in the pharmaceutical industry. This evolution into a formidable pharmaceutical manufacturing powerhouse is characterised by a remarkable growth trajectory driven by substantial investments from international leaders and innovative local enterprises. The market is poised to reach SG$2.2 billion ($1.7 billion) by 2026, reflecting the resounding success of governmental initiatives, notably the establishment of the Biopolis research hub and the Experimental Drug Development Centre (EDDC). Prominent global […]
Click here to view original web page at www.biospectrumasia.com
